Header cover image

Insurance Healthcare Sector

Results

2309

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,309 companies

Venus Concept

Market Cap: US$2.3m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

VERO

US$2.20

7D

-9.5%

1Y

-67.8%

Modern Mobility Aids

Market Cap: US$2.3m

Operates in the telehealth and telemedicine industry.

MDRM

US$0.0036

7D

-56.1%

1Y

-44.6%

One World Products

Market Cap: US$2.3m

One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.

OWPC

US$0.022

7D

5.2%

1Y

-62.2%

PHSC

Market Cap: UK£1.7m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

PHSC

UK£0.17

7D

0%

1Y

-28.3%

Me Today

Market Cap: NZ$3.8m

Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.

MEE

NZ$0.07

7D

9.4%

1Y

-42.6%

NewGenIvf Group

Market Cap: US$2.2m

An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

NIVF

US$2.95

7D

-12.7%

1Y

-98.7%

Cambium Bio

Market Cap: AU$3.5m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

CMB

AU$0.19

7D

0%

1Y

-72.9%

Neural Therapeutics

Market Cap: CA$3.1m

A drug discovery company, focuses on plant-based active substances.

NURL

CA$0.035

7D

0%

1Y

n/a

Vectus Biosystems

Market Cap: AU$3.5m

Engages in the medical research and development activities in Australia.

VBS

AU$0.065

7D

0%

1Y

-67.5%

Helius Medical Technologies

Market Cap: US$2.2m

A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

HSDT

US$4.27

7D

1.7%

1Y

-80.8%

AXIM Biotechnologies

Market Cap: US$2.2m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

AXIM

US$0.0072

7D

-7.7%

1Y

-28.5%

Lifeline Biotechnologies

Market Cap: US$2.2m

Operates as a medical technology company in the United States.

LLBO

US$0.0004

7D

-20.0%

1Y

0%

TALi Digital

Market Cap: AU$3.3m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.

TD1

AU$0.001

7D

0%

1Y

-50.0%

Strainsforpains

Market Cap: US$2.1m

Operates as a medical marijuana data recommendation system.

EBYH

US$0.16

7D

0%

1Y

26.4%

CannaPharmaRX

Market Cap: US$2.1m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

CPMD

US$0.0031

7D

-6.1%

1Y

-69.0%

Aptevo Therapeutics

Market Cap: US$2.1m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

APVO

US$0.32

7D

-5.9%

1Y

-98.9%

Revitalist Lifestyle and Wellness

Market Cap: CA$2.8m

Operates medical clinics.

CALM

CA$0.02

7D

0%

1Y

-80.0%

Entero Therapeutics

Market Cap: US$2.0m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

ENTO

US$0.42

7D

1.3%

1Y

-85.8%

Diagnamed Holdings

Market Cap: CA$2.8m

Engages in the development and commercialization of AI healthcare solutions.

DMED

CA$0.04

7D

100.0%

1Y

0%

Traack Technologies

Market Cap: US$2.0m

Provides business and finance advisory services for small and medium sized companies.

TRAA

US$0.18

7D

0%

1Y

88.1%

Agentix

Market Cap: US$2.0m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

AGTX

US$0.05

7D

0%

1Y

41.0%

TNF Pharmaceuticals

Market Cap: US$2.0m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

TNFA

US$0.19

7D

-0.6%

1Y

-92.0%

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

CFT

CA$0.045

7D

0%

1Y

50.0%

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

RTI.H

CA$0.005

7D

0%

1Y

n/a

JRSIS Health Care

Market Cap: US$1.9m

Develops and produces medical technology and equipment in the People’s Republic of China.

JRSS

US$0.023

7D

0%

1Y

n/a

DXS International

Market Cap: UK£1.4m

A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.

DXSP

UK£0.022

7D

0%

1Y

66.7%

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

KNB

UK£0.0022

7D

0%

1Y

-86.8%

Universe Pharmaceuticals

Market Cap: US$1.9m

Through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.

UPC

US$5.49

7D

12.5%

1Y

-99.6%

Aditxt

Market Cap: US$1.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

ADTX

US$1.66

7D

-4.0%

1Y

-100.0%

ZyVersa Therapeutics

Market Cap: US$1.9m

Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.

ZVSA

US$0.52

7D

-0.8%

1Y

-88.3%

Medical Marijuana

Market Cap: US$1.9m

An investment holding company, operates in the cannabinoid-based nutraceutical industry.

MJNA

US$0.00025

7D

-16.7%

1Y

-88.1%

Careteq

Market Cap: AU$2.8m

A medication management services company for health, aged, and home care sectors worldwide.

CTQ

AU$0.012

7D

-7.7%

1Y

-14.3%

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

GRTX

US$0.024

7D

6.2%

1Y

-87.8%

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

HELD

UK£0.0095

7D

0%

1Y

-75.3%

ENDRA Life Sciences

Market Cap: US$1.8m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.

NDRA

US$3.23

7D

-0.9%

1Y

-99.4%

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

OMID

US$0.018

7D

-15.9%

1Y

-38.3%

Page 47 of 65